Synovus Financial’s Clearside Biomedical CLSD Stock Holding History

Synovus Financial’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$24K	–	944
2025 Q2	$24K	Hold	2,000	–	–	﹤0.01%	907
2025 Q1	$27.5K	Hold	2,000	–	–	﹤0.01%	892
2024 Q4	$28.5K	Sell	2,000 -1,538	-43%	-$25.3K	﹤0.01%	871
2024 Q3	$67.4K	Hold	3,538	–	–	﹤0.01%	903
2024 Q2	$69K	Hold	3,538	–	–	﹤0.01%	834
2024 Q1	$81.2K	Hold	3,538	–	–	﹤0.01%	835
2023 Q4	$62.1K	Sell	3,538 -333	-9%	-$4.75K	﹤0.01%	814
2023 Q3	$50.5K	Hold	3,871	–	–	﹤0.01%	827
2023 Q2	$65K	Hold	3,871	–	–	﹤0.01%	828
2023 Q1	$60.4K	Sell	3,871 -452	-10%	-$8.78K	﹤0.01%	812
2022 Q4	$72.6K	Hold	4,323	–	–	﹤0.01%	843
2022 Q3	$74K	Hold	4,323	–	–	﹤0.01%	829
2022 Q2	$95K	Sell	4,323 -667	-13%	-$16.2K	﹤0.01%	825
2022 Q1	$171K	Buy	4,990 +3,119	+167%	+$93.3K	﹤0.01%	820
2021 Q4	$77K	Hold	1,871	–	–	﹤0.01%	847
2021 Q3	$168K	Hold	1,871	–	–	﹤0.01%	815
2021 Q2	$136K	Hold	1,871	–	–	﹤0.01%	818
2021 Q1	$69K	Hold	1,871	–	–	﹤0.01%	741
2020 Q4	$77K	Buy	+1,871	New	+$48.5K	﹤0.01%	752
2019 Q4	–	Sell	-333	Closed	-$3K	–	1553
2019 Q3	$3K	Hold	333	–	–	﹤0.01%	1344
2019 Q2	$5K	Hold	333	–	–	﹤0.01%	1213
2019 Q1	$7K	Hold	333	–	–	﹤0.01%	1168
2018 Q4	$5K	Sell	333 -34	-9%	-$1.59K	﹤0.01%	1192
2018 Q3	$34K	Hold	367	–	–	﹤0.01%	915
2018 Q2	$59K	Hold	367	–	–	﹤0.01%	759
2018 Q1	$59K	Buy	+367	New	+$44.7K	﹤0.01%	749
2017 Q2	–	Sell	-233	Closed	-$28K	–	842
2017 Q1	$28K	Buy	233 +133	+133%	+$15.7K	﹤0.01%	808
2016 Q4	$13K	Buy	+100	New	+$25.1K	﹤0.01%	886

Other funds holding CLSD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Synovus Financial's CLSD Position: Q3 2025 in Review

Synovus Financial sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 2,000 shares — an estimated $24K sold.

Synovus Financial first reported a position in CLSD in Q4 2016 and held it in 28 quarters. The position peaked at $171K in Q1 2022. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

Synovus Financial reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
Synovus Financial sold 2,000 Clearside Biomedical shares in Q3 2025, an estimated $24K.
Synovus Financial first reported a position in Clearside Biomedical in Q4 2016 and held it in 28 quarters.
Synovus Financial's Clearside Biomedical position peaked at $171K in Q1 2022.
26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.